Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 428210, 11 pages
http://dx.doi.org/10.1155/2014/428210
Research Article

An Investigation of Small GTPases in relation to Liver Tumorigenesis Using Traditional Chinese Medicine

1Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Neurosurgery, China Medical University Hospital, No. 2 Yude Road, North District, Taichung 40447, Taiwan
4Department of Anesthesiology, China Medical University Hospital, Taichung 40447, Taiwan
5Research Center for Chinese Medicine & Acupuncture, China Medical University, Taichung 40402, Taiwan
6Human Genetic Center, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan

Received 25 February 2014; Revised 5 March 2014; Accepted 5 March 2014; Published 19 June 2014

Academic Editor: Chung Y. Hsu

Copyright © 2014 Tzu-Chieh Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. W. Chew, X. J. Liu, L. Liu, J. M. Spitsbergen, Z. Gong, and B. C. Low, “Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models,” Oncogene, vol. 33, no. 21, pp. 2717–2727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Baines, D. Xu, and C. J. Der, “Inhibition of Ras for cancer treatment: the search continues,” Future Medicinal Chemistry, vol. 3, no. 14, pp. 1787–1808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Ostrem, U. Peters, M. L. Sos, J. A. Wells, and K. M. Shokat, “K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions,” Nature, vol. 503, no. 7477, pp. 548–551, 2013. View at Google Scholar
  4. Q. Sun, J. P. Burke, J. Phan et al., “Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation,” Angewandte Chemie International Edition, vol. 51, no. 25, pp. 6140–6143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-J. Huang, H. W. Yu, C.-Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. W. I. Tou, S.-S. Chang, C.-C. Lee, and C. Y.-C. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar · View at Scopus
  7. C. Y.-C. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Y.-C. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. W.-L. Liao and F.-J. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-C. Lee, C.-H. Tsai, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Google Scholar
  11. I. C. Chou, W.-D. Lin, C.-H. Wang et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Publisher · View at Google Scholar
  12. C. Y. C. Chen, “TCM database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Google Scholar
  13. H.-J. Huang, K.-J. Lee, H. W. Yu et al., “Structure-based and ligand-based drug design for HER 2 receptor,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 1, pp. 23–37, 2010. View at Google Scholar · View at Scopus
  14. W. I. Tou and C. Y.-C. Chen, “Traditional Chinese medicine as dual guardians against hypertension and cancer?” Journal of Biomolecular Structure and Dynamics, vol. 30, no. 3, pp. 299–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-C. Yang, S.-S. Chang, and C. Y.-C. Chen, “Identifying HER2 inhibitors from natural products database,” PLoS ONE, vol. 6, no. 12, Article ID e28793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-Y. Chen and C. Y.-C. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Chang, H. J. Huang, and C. Y. C. Chen, “High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM database@Taiwan,” Molecular BioSystems, vol. 7, no. 12, pp. 3366–3374, 2011. View at Google Scholar
  18. S.-S. Chang, H.-J. Huang, and C. Y.-C. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-Y. Chen, Y.-H. Chang, D.-T. Bau et al., “Ligand-based dual target drug design for H1N1: swine flu—a preliminary first study,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 2, pp. 171–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T.-Y. Tsai, K.-W. Chang, and C. Y.-C. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-W. Chang, T.-Y. Tsai, K.-C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, vol. 19, no. 4, pp. 367–372, 2014. View at Publisher · View at Google Scholar
  23. C. M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, “LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites,” Journal of Molecular Graphics and Modelling, vol. 21, no. 4, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. B. R. Brooks, C. L. Brooks III, A. D. Mackerell Jr. et al., “CHARMM: the biomolecular simulation program,” Journal of Computational Chemistry, vol. 30, no. 10, pp. 1545–1614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Laskowski and M. B. Swindells, “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Google Scholar · View at Scopus
  27. U. D. Priyakumar and A. D. MacKerell, “Comparison of the CHARMM27, AMBER4.1 and BMS nucleic acid force fields via free energy calculations of base flipping,” Abstracts of Papers of the American Chemical Society, vol. 230, pp. U1391–U1392, 2005. View at Google Scholar
  28. B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. A. Darden and L. G. Pedersen, “Molecular modeling: an experimental tool,” Environmental Health Perspectives, vol. 101, no. 5, pp. 410–412, 1993. View at Google Scholar · View at Scopus
  31. M. Yoshikawa, S. Hatakeyama, Y. Inoue, and J. Yamahara, “Saussureamines A, B, C, D, and E, new anti-ulcer principles from Chinese saussureae radix,” Chemical and Pharmaceutical Bulletin, vol. 41, no. 1, pp. 214–216, 1993. View at Google Scholar · View at Scopus
  32. Y. K. Choi, S. G. Cho, S. M. Woo et al., “Saussurea lappa clarke-derived costunolide prevents TNF alpha-induced breast cancer cell migration and invasion by inhibiting NF-kappa B activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 936257, 10 pages, 2013. View at Publisher · View at Google Scholar
  33. O. P. Upadhyay, J. K. Ojha, H. S. Bajpai, and A. K. Hathwal, “Study of kustha (Saussurea lappa, clarke) in ischaemic heart disease,” Ancient Science of Life, vol. 13, no. 1-2, pp. 11–18, 1993. View at Google Scholar
  34. T. S. Saleem, N. Lokanath, A. Prasanthi, M. Madhavi, G. Mallika, and M. N. Vishnu, “Aqueous extract of Saussurea lappa root ameliorate oxidative myocardial injury induced by isoproterenol in rats,” Journal of Advanced Pharmaceutical Technology and Research, vol. 4, no. 2, pp. 94–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Yaeesh, Q. Jamal, A. J. Shah, and A. H. Gilani, “Antihepatotoxic activity of Saussurea lappa extract on D-galactosamine and lipopolysaccharide-induced hepatitis in mice,” Phytotherapy Research, vol. 24, supplement 2, pp. S229–S232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Taniguchi, T. Kataoka, H. Suzuki et al., “Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytes,” Bioscience, Biotechnology and Biochemistry, vol. 59, no. 11, pp. 2064–2067, 1995. View at Google Scholar · View at Scopus
  37. S. H. A. Seddiek, M. M. El-Shorbagy, H. F. Khater, and A. M. Ali, “The antitrichomonal efficacy of garlic and metronidazole against Trichomonas gallinae infecting domestic pigeons,” Parasitology Research, vol. 113, no. 4, pp. 1319–1329, 2014. View at Google Scholar
  38. Y. Liu, M. Song, T. M. Che et al., “Dietary plant extracts modulate gene expression profiles in ileal mucosa of weaned pigs after an Escherichia coli infection,” Journal of Animal Science, vol. 92, pp. 2050–2062, 2014. View at Publisher · View at Google Scholar
  39. R. Snowden, H. Harrington, K. Morrill et al., “A comparison of the anti-Staphylococcus aureus activity of extracts from commonly used medicinal plants,” Journal of Alternative and Complementary Medicine, vol. 20, no. 5, pp. 375–382, 2014. View at Publisher · View at Google Scholar
  40. G. M. Suddek, “Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals,” Pharmaceutical Biology. In press.
  41. J. Xiao, Y. P. Ching, E. C. Liong, A. A. Nanji, M. L. Fung, and G. L. Tipoe, “Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model,” European Journal of Nutrition, vol. 52, no. 1, pp. 179–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Xiao, R. Guo, M.-L. Fung et al., “Garlic-derived S-allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 642920, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Xiao, E. C. Liong, M.-T. Ling, Y.-P. Ching, M.-L. Fung, and G. L. Tipoe, “S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice,” European Journal of Nutrition, vol. 51, no. 3, pp. 323–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Liang, Y. Qin, W. Zhao et al., “S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions,” Cancer Letters, vol. 310, no. 1, pp. 69–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Lee, H. Kim, J. Lee, and K. Kim, “Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell,” Biological and Pharmaceutical Bulletin, vol. 34, no. 5, pp. 677–681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Miyazaki, M. Hardjo, T. Masaka et al., “Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure,” Stem Cells, vol. 25, no. 11, pp. 2855–2863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Tokiwa, T. Yamazaki, W. Xin et al., “Differentiation potential of an immortalized non-tumorigenic human liver epithelial cell line as liver progenitor cells,” Cell Biology International, vol. 30, no. 12, pp. 992–998, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. H. Peters and B. L. de Groot, “Ubiquitin dynamics in complexes reveal molecular recognition mechanisms beyond induced fit and conformational selection,” PLoS Computational Biology, vol. 8, no. 10, Article ID e1002704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Chovancova, A. Pavelka, P. Benes et al., “CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures,” PLoS Computational Biology, vol. 8, no. 10, Article ID e1002708, 2012. View at Publisher · View at Google Scholar · View at Scopus